Success Metrics

Clinical Success Rate

75.0%

Based on 9 completed trials

Completion Rate

75%(9/12)

Active Trials

0(0%)

Results Posted

33%(3 trials)

Terminated

3(17%)

Phase Distribution

Ph not_applicable

17%

Ph phase_3

11%

Ph phase_1

11%

Ph phase_4

50%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution16 total trials

Phase 1Safety & dosage

2(12.5%)

Phase 3Large-scale testing

2(12.5%)

Phase 4Post-market surveillance

9(56.3%)

N/ANon-phased studies

3(18.8%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

64.3%

9 of 14 finished

Non-Completion Rate

35.7%

5 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Completed(9)

Terminated(5)

Other(4)

Detailed Status

Completed9

unknown4

Terminated3

Withdrawn2

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

75.0%

Most Advanced

Phase 4

Trials by Phase

Phase 12 (12.5%)

Phase 32 (12.5%)

Phase 49 (56.3%)

N/A3 (18.8%)

Trials by Status

completed950%

terminated317%

unknown422%

withdrawn211%

Recent Activity

0 active trials

Showing 5 of 18

unknown

Safety and Efficacy Study to Compare Smoflipid and Intralipid 20% in Pediatric Patients of 3 Months to 16 Years of Age

NCT03563222

completedphase_3

Lipid Emulsion Infusion and COVID-19 Patients

NCT04957940

View all 18 trials

Clinical Trials (18)

Showing 18 of 18 trials

NCT02412566

SMOF Lipid for Children With Parenteral Nutrition Induced Liver Injury

Unknown

NCT03405870Phase 1

LIPIDS-P Trial Phase I/II Trial

Completed

NCT03773237Not Applicable

Intralipid Versus SMOFlipid in HPN Patients

Completed

NCT03563222Phase 4

Safety and Efficacy Study to Compare Smoflipid and Intralipid 20% in Pediatric Patients of 3 Months to 16 Years of Age

Terminated

NCT04957940Phase 3

Lipid Emulsion Infusion and COVID-19 Patients

Completed

NCT04951791Not Applicable

Lipid Emulsion in Cardiac Valve Replacement Surgery

Unknown

NCT04572373

Supplements SMOF in TPN for Liver Transplantation Recipients

Completed

NCT04277923Phase 4

Effects of Fat Emulsions on PNALD and Oxidative Stress in Premature Infants

Unknown

NCT02853253Phase 4

Rate of Bronchopulmonary Dysplasia in Preterms Neonates: a Trial Comparing SMOFlipid and Medialipide

Withdrawn

NCT03275090Phase 4

The Effects of Two Different Intravenous Lipid Emulsions on the Outcomes of Preterm Infants With Sepsis

Completed

NCT03054948Phase 4

SMOFLipid in Patients Who Are Intralipid Intolerant

Withdrawn

NCT01585935Phase 4

Preventing Cholestasis Using SMOFLipid®

Completed

NCT02633384Phase 4

Reduction of Neonatal Parenteral Nutrition Associated Cholestasis Through Lipid Emulsions

Terminated

NCT02721277Phase 1

SMOFlipid to Lessen the Severity of Neonatal Cholestasis

Terminated

NCT02539316Phase 4

Pilot Study: Hepatoprotective Role of SMOFlipid® Used in Short-term Parenteral Nutrition in an Onco-Hematology Pediatric Population

Completed

NCT01957943Not Applicable

Omega 3 Lipid Emulsions and Liver Transplantation

Unknown

NCT02760472Phase 3

A Fatty Acids Study in Preventing Retinopathy of Prematurity

Completed

NCT00600912Phase 4

Influence of of a Lipid Emulsion on Inflammatory Response and Hepatic Function

Completed

All 18 trials loaded

Drug Details

Intervention Type: DRUG
Total Trials: 18